Literature DB >> 25046031

Lacosamide-induced atrial tachycardia in a child with hypoplastic left-heart syndrome: the importance of assessing additional proarrhythmic risks.

Rohit S Loomba1, Anoop K Singh1, Joshua Kovach1, Todd M Gudausky1.   

Abstract

Antiepileptic medications have been reported to cause disturbances in cardiac conduction. Lacosamide decreases seizure burden by modulating sodium channels. Although it has been demonstrated to have few side effects, there have been reports of clinically significant cardiac conduction disturbances. We report the case of a child with hypoplastic left-heart syndrome and well-controlled multifocal atrial tachycardia who developed haemodynamically significant atrial tachycardia after receiving two doses of lacosamide.

Entities:  

Keywords:  flecainide

Mesh:

Substances:

Year:  2014        PMID: 25046031     DOI: 10.1017/S1047951114001188

Source DB:  PubMed          Journal:  Cardiol Young        ISSN: 1047-9511            Impact factor:   1.093


  2 in total

1.  Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.

Authors:  David G Vossler; Jacquelyn L Bainbridge; Jane G Boggs; Edward J Novotny; Tobias Loddenkemper; Edward Faught; Marta Amengual-Gual; Sarah N Fischer; David S Gloss; Donald M Olson; Alan R Towne; Dean Naritoku; Timothy E Welty
Journal:  Epilepsy Curr       Date:  2020-08-21       Impact factor: 7.500

Review 2.  Lacosamide-Related Arrhythmias: A Systematic Analysis and Review of the Literature.

Authors:  Ruchi Yadav; Ezra Schrem; Vivek Yadav; Amog Jayarangaiah; Sushruth Das; Pramod Theetha Kariyanna
Journal:  Cureus       Date:  2021-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.